Tenderwize
Wróć do wyszukiwania

Supply of Pharmaceutical Products

МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - БОТЕВГРАД ЕООД·гр. Ботевград, Bulgaria·BGN 566.2k·Deadline Sep 26, 2028 · 760 days left·Restricted·Supplies·DPS
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Bulgaria – Pharmaceutical products – Динамична система за покупки ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МБАЛ - БОТЕВГРАД“ ЕООД за период от 3 години

40/100

Ocena szansy

Needs reviewMedium complexity
SuppliesDPSOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

50 / 100

Czynniki ryzyka

No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...

Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...

Restricted procedure — pre-qualification required

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • BGN 566.2k estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 36 MONTH
  • Supply of pharmaceutical products (CPV 33600000) to MBAL-Botevgrad Hospital.
  • DPS duration of 36 months.
Pokaż pełne podsumowanie

This notice establishes a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL-Botevgrad Hospital in Bulgaria for a period of 3 years. The DPS is divided into a single lot covering all pharmaceutical products. The estimated total value is 566,202 BGN. The procedure is restricted, with award based on lowest price. Participation requires a wholesale authorization for medicinal products. The notice publication date is 2025-09-29, and the deadline for admission to the DPS is 2028-09-26. No procurement documents were analyzed.

Ryzyka

No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...

Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...

Restricted procedure — pre-qualification required

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must hold a wholesale authorization for medicinal products issued by the Bulgarian Drug Agency or equivalent.

Administrative

  • Must submit an ESPD (European Single Procurement Document) with Part IV, Section A completed.
  • Electronic submission via the CAIS EOP platform is required.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

Lowest price (no weight specified).

Zamawiający

Lokalizacja

гр. Ботевград, BGR

Profil zamawiającego

Otwórz profil

Identyfikator

000770022

Działalność

Health

Części (1)

LOT-0001

Supply of Pharmaceutical Products

Supply of various medicinal products to MBAL-Botevgrad Hospital over a 3-year period. Quantities are indicative and non-binding.

SuppliesDPSEU fundedElectronic submission

BGN 566.2k

Szacowana wartość

Lokalizacja

Ботевград, Bulgaria

Czas trwania

36 MONTH

Kategoria

Pharmaceutical products

Kryteria udzielenia

Price

Termin

Deadline Sep 26, 2028

Szczegóły zamówienia

Data publikacji
28 Sep 2025
Języki
Bulgarian

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
633535-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30